Related Experiment Video
Updated: Mar 26, 2026

08:59
Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
3.2K
Amyotrophic lateral sclerosis causes small fiber pathology
E Dalla Bella1,2, R Lombardi2, C Porretta-Serapiglia2
1Motor Neuron Diseases Centre, IRCCS Foundation 'Carlo Besta' Neurological Institute, Milan, Italy.
European Journal of Neurology
|January 26, 2016
Summary
Small fiber loss, indicated by reduced intraepidermal nerve fiber density, is common in amyotrophic lateral sclerosis (ALS) patients. However, this nerve damage does not correlate with disease characteristics or serve as a clinical biomarker.
Area of Science:
- Neurology
- Neuroscience
- Pathology
Background:
- Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease.
- Small fiber neuropathy is a potential comorbidity in neurological disorders.
- The relationship between small fiber loss and ALS progression is not well understood.
Purpose of the Study:
- To investigate the correlation between small fiber loss and amyotrophic lateral sclerosis (ALS).
- To examine the association of small fiber loss with disease onset, phenotype, genotype, duration, severity, and sensory findings in ALS patients.
Main Methods:
- Consecutive patients with suspected ALS were evaluated.
- Sural nerve conduction studies (NCS) and skin biopsies for intraepidermal nerve fiber (IENF) density quantification were performed.
- Genetic analysis and clinical assessments including the ALS Functional Rating Scale-Revised were conducted.
Main Results:
- Reduced IENF density was observed in a majority of ALS patients (75.4%) and facial onset sensory and motor neuronopathy (FOSMN) patients (50%).
- No significant correlation was found between IENF density and ALS onset, phenotype, genotype, disease duration, or severity.
- Sensory disturbances were reported by a subset of ALS and FOSMN patients, with normal sural NCS in most cases.
Conclusions:
- Intraepidermal nerve fiber loss is a prevalent finding in most ALS patients.
- Small fiber loss in ALS does not correlate with disease characteristics and lacks clinical or prognostic utility as a biomarker.
Related Concept Videos
Cross-bridge Cycle
124.7K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
124.7K
Chemical Synapses
12.4K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
12.4K
Chemical Synapses
8.3K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.3K
Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
Amyloid Fibrils
12.9K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.9K
Amyloid Fibrils
6.9K
6.9K

